JAZZ logo

Jazz Pharmaceuticals plc (JAZZ) Free cash flow

annual FCF:

$1.36B+$289.79M(+27.13%)
December 31, 2024

Summary

  • As of today (September 1, 2025), JAZZ annual free cash flow is $1.36 billion, with the most recent change of +$289.79 million (+27.13%) on December 31, 2024.
  • During the last 3 years, JAZZ annual FCF has risen by +$624.86 million (+85.25%).
  • JAZZ annual FCF is now at all-time high.

Performance

JAZZ Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZcash flow metrics

quarterly FCF:

$75.89M-$315.01M(-80.59%)
June 30, 2025

Summary

  • As of today (September 1, 2025), JAZZ quarterly free cash flow is $75.89 million, with the most recent change of -$315.01 million (-80.59%) on June 30, 2025.
  • Over the past year, JAZZ quarterly FCF has dropped by -$248.37 million (-76.60%).
  • JAZZ quarterly FCF is now -82.06% below its all-time high of $422.89 million, reached on September 30, 2022.

Performance

JAZZ quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZcash flow metrics

TTM FCF:

$1.24B-$248.37M(-16.69%)
June 30, 2025

Summary

  • As of today (September 1, 2025), JAZZ TTM free cash flow is $1.24 billion, with the most recent change of -$248.37 million (-16.69%) on June 30, 2025.
  • Over the past year, JAZZ TTM FCF has increased by +$195.32 million (+18.70%).
  • JAZZ TTM FCF is now -16.69% below its all-time high of $1.49 billion, reached on March 31, 2025.

Performance

JAZZ TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

JAZZ Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+27.1%-76.6%+18.7%
3 y3 years+85.3%-73.9%+41.2%
5 y5 years+128.6%-1.2%+159.3%

JAZZ Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+85.3%-82.1%at low-16.7%+41.2%
5 y5-yearat high+160.9%-82.1%+119.9%-16.7%+172.6%
alltimeall timeat high+954.1%-82.1%+226.9%-16.7%+864.4%

JAZZ Free cash flow History

DateAnnualQuarterlyTTM
Jun 2025
-
$75.89M(-80.6%)
$1.24B(-16.7%)
Mar 2025
-
$390.90M(+1.5%)
$1.49B(+9.6%)
Dec 2024
$1.36B(+27.1%)
$385.29M(-0.7%)
$1.36B(+20.2%)
Sep 2024
-
$387.96M(+19.6%)
$1.13B(+8.1%)
Jun 2024
-
$324.26M(+24.6%)
$1.04B(+3.3%)
Mar 2024
-
$260.32M(+65.6%)
$1.01B(-5.3%)
Dec 2023
$1.07B(-12.3%)
$157.24M(-48.1%)
$1.07B(-14.1%)
Sep 2023
-
$302.90M(+4.1%)
$1.24B(-8.8%)
Jun 2023
-
$291.03M(-8.2%)
$1.36B(+0.0%)
Mar 2023
-
$316.89M(-4.7%)
$1.36B(+11.9%)
Dec 2022
$1.22B(+66.2%)
$332.59M(-21.4%)
$1.22B(+15.6%)
Sep 2022
-
$422.89M(+45.4%)
$1.05B(+19.9%)
Jun 2022
-
$290.76M(+69.4%)
$878.07M(+41.2%)
Mar 2022
-
$171.69M(+2.3%)
$621.83M(-15.2%)
Dec 2021
$732.98M(+40.9%)
$167.79M(-32.3%)
$732.98M(+3.0%)
Sep 2021
-
$247.84M(+618.0%)
$711.34M(+0.5%)
Jun 2021
-
$34.52M(-87.8%)
$708.02M(-5.6%)
Mar 2021
-
$282.83M(+93.5%)
$750.33M(+44.2%)
Dec 2020
$520.39M(-12.4%)
$146.16M(-40.2%)
$520.39M(+14.4%)
Sep 2020
-
$244.52M(+218.3%)
$454.90M(-4.9%)
Jun 2020
-
$76.83M(+45.3%)
$478.30M(-6.0%)
Mar 2020
-
$52.89M(-34.4%)
$508.65M(-14.4%)
Dec 2019
$594.07M(-10.1%)
$80.66M(-69.9%)
$594.07M(-18.9%)
Sep 2019
-
$267.92M(+150.0%)
$732.60M(+7.5%)
Jun 2019
-
$107.18M(-22.5%)
$681.32M(+5.8%)
Mar 2019
-
$138.31M(-36.9%)
$644.12M(-2.6%)
Dec 2018
$661.03M(+14.1%)
$219.20M(+1.2%)
$661.03M(+5.0%)
Sep 2018
-
$216.64M(+209.6%)
$629.51M(+21.4%)
Jun 2018
-
$69.98M(-54.9%)
$518.42M(-9.6%)
Mar 2018
-
$155.21M(-17.3%)
$573.38M(-1.0%)
Dec 2017
$579.14M(+41.6%)
$187.68M(+77.8%)
$579.14M(+1.4%)
Sep 2017
-
$105.55M(-15.5%)
$570.87M(-1.7%)
Jun 2017
-
$124.94M(-22.4%)
$580.97M(+35.3%)
Mar 2017
-
$160.97M(-10.3%)
$429.49M(+5.0%)
Dec 2016
$408.95M(-17.5%)
$179.42M(+55.1%)
$408.95M(+18.2%)
Sep 2016
-
$115.65M(-535.7%)
$345.91M(-13.6%)
Jun 2016
-
-$26.54M(-118.9%)
$400.18M(-27.8%)
Mar 2016
-
$140.43M(+20.7%)
$554.27M(+11.8%)
DateAnnualQuarterlyTTM
Dec 2015
$495.99M(+34.3%)
$116.37M(-31.5%)
$495.99M(-29.2%)
Sep 2015
-
$169.92M(+33.2%)
$700.48M(+21.4%)
Jun 2015
-
$127.55M(+55.3%)
$577.13M(+12.9%)
Mar 2015
-
$82.14M(-74.4%)
$511.37M(+38.4%)
Dec 2014
$369.42M(+35.6%)
$320.87M(+589.2%)
$369.42M(+196.4%)
Sep 2014
-
$46.56M(-24.7%)
$124.65M(-39.4%)
Jun 2014
-
$61.79M(-203.3%)
$205.73M(+38.0%)
Mar 2014
-
-$59.80M(-178.6%)
$149.09M(-45.3%)
Dec 2013
$272.34M(+19.8%)
$76.11M(-40.4%)
$272.34M(-7.3%)
Sep 2013
-
$127.64M(+2377.4%)
$293.85M(+42.2%)
Jun 2013
-
$5.15M(-91.9%)
$206.60M(-22.9%)
Mar 2013
-
$63.45M(-35.0%)
$267.96M(+17.9%)
Dec 2012
$227.28M(+55.9%)
$97.61M(+141.6%)
$227.28M(+32.6%)
Sep 2012
-
$40.39M(-39.3%)
$171.44M(-2.4%)
Jun 2012
-
$66.51M(+192.2%)
$175.61M(+20.8%)
Mar 2012
-
$22.76M(-45.5%)
$145.32M(-0.3%)
Dec 2011
$145.82M(+169.3%)
$41.78M(-6.3%)
$145.82M(+8.7%)
Sep 2011
-
$44.57M(+23.1%)
$134.20M(+25.7%)
Jun 2011
-
$36.22M(+55.7%)
$106.81M(+48.4%)
Mar 2011
-
$23.26M(-22.9%)
$71.98M(+33.0%)
Dec 2010
$54.14M(-377.4%)
$30.16M(+75.7%)
$54.14M(+115.2%)
Sep 2010
-
$17.17M(+1134.4%)
$25.16M(-558.4%)
Jun 2010
-
$1.39M(-74.3%)
-$5.49M(-31.0%)
Mar 2010
-
$5.41M(+358.8%)
-$7.95M(-59.3%)
Dec 2009
-$19.52M(-87.7%)
$1.18M(-108.8%)
-$19.52M(-58.1%)
Sep 2009
-
-$13.47M(+1159.1%)
-$46.56M(-24.7%)
Jun 2009
-
-$1.07M(-82.6%)
-$61.83M(-46.9%)
Mar 2009
-
-$6.16M(-76.2%)
-$116.50M(-26.7%)
Dec 2008
-$158.97M(+88.7%)
-$25.86M(-10.0%)
-$158.97M(-2.0%)
Sep 2008
-
-$28.75M(-48.4%)
-$162.22M(+8.6%)
Jun 2008
-
-$55.74M(+14.6%)
-$149.43M(+33.8%)
Mar 2008
-
-$48.63M(+67.1%)
-$111.68M(+32.6%)
Dec 2007
-$84.24M(+42.7%)
-$29.10M(+82.3%)
-$84.24M(+52.8%)
Sep 2007
-
-$15.96M(-11.2%)
-$55.14M(+40.8%)
Jun 2007
-
-$17.99M(-15.1%)
-$39.17M(+84.9%)
Mar 2007
-
-$21.18M
-$21.18M
Dec 2006
-$59.03M(+10.2%)
-
-
Dec 2005
-$53.58M(+141.9%)
-
-
Dec 2004
-$22.15M
-
-

FAQ

  • What is Jazz Pharmaceuticals plc annual free cash flow?
  • What is the all time high annual FCF for Jazz Pharmaceuticals plc?
  • What is Jazz Pharmaceuticals plc annual FCF year-on-year change?
  • What is Jazz Pharmaceuticals plc quarterly free cash flow?
  • What is the all time high quarterly FCF for Jazz Pharmaceuticals plc?
  • What is Jazz Pharmaceuticals plc quarterly FCF year-on-year change?
  • What is Jazz Pharmaceuticals plc TTM free cash flow?
  • What is the all time high TTM FCF for Jazz Pharmaceuticals plc?
  • What is Jazz Pharmaceuticals plc TTM FCF year-on-year change?

What is Jazz Pharmaceuticals plc annual free cash flow?

The current annual FCF of JAZZ is $1.36B

What is the all time high annual FCF for Jazz Pharmaceuticals plc?

Jazz Pharmaceuticals plc all-time high annual free cash flow is $1.36B

What is Jazz Pharmaceuticals plc annual FCF year-on-year change?

Over the past year, JAZZ annual free cash flow has changed by +$289.79M (+27.13%)

What is Jazz Pharmaceuticals plc quarterly free cash flow?

The current quarterly FCF of JAZZ is $75.89M

What is the all time high quarterly FCF for Jazz Pharmaceuticals plc?

Jazz Pharmaceuticals plc all-time high quarterly free cash flow is $422.89M

What is Jazz Pharmaceuticals plc quarterly FCF year-on-year change?

Over the past year, JAZZ quarterly free cash flow has changed by -$248.37M (-76.60%)

What is Jazz Pharmaceuticals plc TTM free cash flow?

The current TTM FCF of JAZZ is $1.24B

What is the all time high TTM FCF for Jazz Pharmaceuticals plc?

Jazz Pharmaceuticals plc all-time high TTM free cash flow is $1.49B

What is Jazz Pharmaceuticals plc TTM FCF year-on-year change?

Over the past year, JAZZ TTM free cash flow has changed by +$195.32M (+18.70%)
On this page